Home / Conditions / Vertebrogenic Low Back Pain
Vertebrogenic Low Back Pain: when insurers say no, reviewers often say yes
In 21 published external-review decisions involving vertebrogenic low back pain, independent physician reviewers overturned the insurer’s denial 47.6% of the time.
Published decisions
21
2001–2026
Overturned
47.6%
10 denials reversed
Most-fought treatments for vertebrogenic low back pain
What insurers denied — and how those fights ended.
| Treatment | Decisions | Overturned |
|---|---|---|
| Intracept Procedure | 16 | 43.8% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 15 | 53.3% |
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 6 | 33.3% |
Typical time to a decision
7 days
Most land between 3 and 11 days
Handled as urgent
71.4%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for the Intracept procedure. In a randomized control trial evaluating the effectiveness of intraosseous radiofrequency ablation of the basivertebral nerve to standard treatment of chronic low back pain in a specific subgroup of patients suspected to have vertebrogenic related symptomatology, researchers found clear statistical superiority for all primary and secondary patient-reported outcome measures in the radiofrequency ablation arm compared with the standard care arm. The authors noted statistically significant improvements in the Oswestry Disability Index (ODI) scores and visual analogue scores (VAS) in the treatment arm compared to the arm receiving standard care.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for Intracept procedure thermal destruction of intraosseous basivertebral nerve (BVN), inclusive of all imaging. A randomized control trial compared the effectiveness of intraosseous radiofrequency (RF) ablation of the BVN (Intracept procedure) to standard treatment for patients with chronic low back pain suspected to have vertebrogenic related symptomatology. The study showed clear statistical superiority of RF ablation over standard treatment for all primary and secondary patient-reported outcome measures. The authors observed that there were statistically significant improvements in patients’ Oswestry Disability Index (ODI) scores and visual analog scale (VAS) with RF ablation compared to standard treatment.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Findings: The physician reviewer found that an enrollee has requested authorization and coverage for the Intercept procedure. In this case, the patient is being treated for vertebrogenic low back pain. In notes, the patient reported sacroiliac joint pain, greater on the left than on the right, that worsened with prolonged sitting. He reported vertebrogenic pain with bending forward. On examination, there was pain with range of motion in all planes, most with flexion, and left-sided sacroiliac joint tenderness. Flexion Abduction External Rotation (FABER), iliac compression, and Gaenslen’s tests were positive on the left. The U.S.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for Intracept procedure. In this case, the patient is being treated for chronic vertebrogenic low back pain, intervertebral disc degeneration of the lumbar region, and intervertebral disc degeneration of the lumbosacral region. In notes, the patient reported neck and back pain, 90% in the back and 10% in the legs. The patient rated her pain at seven out of ten. A lumbar spinal examination reveals tenderness to palpation over the bilateral facet joints and sacroiliac joints, with a limited range of motion secondary to pain and intact sensation, strength, and reflexes. The U.S.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for vertebrogenic low back pain was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.